Table I.
Demographic and clinical characteristics of the study cohort∗
| Age | |
| Range (mean ± SD) | 16-73 (43.7 ± 14.6) |
| Sex | |
| Female | 4 (27) |
| Race/ethnicity | |
| Caucasian | 11 (73) |
| Asian | 1 (7) |
| Middle-eastern | 3 (20) |
| Epidermolysis Bullosa type, subtype | |
| Simplex, localized | 4 (27) |
| Junctional, generalized intermediate | 2 (13) |
| Dominant dystrophic | 6 (40) |
| Recessive dystrophic, generalized intermediate | 2 (13) |
| Recessive dystrophic, generalized severe | 1 (7) |
| Disease severity; corresponding EBDASI score range12 | |
| Mild; 0-42 | 6 (40) |
| Moderate; 43-106 | 6 (40) |
| Severe; 107-506 | 3 (20) |
| Disease severity; iscorEB validation criteria5 | |
| Mild; localized involvement, 0 non-skin complications | 6 (40) |
| Moderate; widespread involvement, <3 non-skin complications | 4 (27) |
| Severe; generalized involvement, ≥3 non-skin complications | 5 (33) |
EBDASI, Epidermolysis Bullosa Disease Activity and Scarring Index; iscorEB, Instrument for scoring the clinical outcomes of research for Epidermolysis Bullosa; SD, standard deviation.
∗
All values are n (%) unless otherwise specified.